These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 4634136)
1. [Mode of action of rifampicin on Mycobacterium tuberculosis]. Konno K; Oizumi K; Hayashi I; Oka S Kekkaku; 1972 Aug; 47(8):255-60. PubMed ID: 4634136 [No Abstract] [Full Text] [Related]
2. Mode of action of rifampin on mycobacteria. II. Biosynthetic studies on the inhibition of ribonucleic acid polymerase of Mycobacterium bovis BCG by rifampin and uptake of rifampin- 14 C by Mycobacterium phlei. Konno K; Oizumi K; Oka S Am Rev Respir Dis; 1973 Jun; 107(6):1006-12. PubMed ID: 4576356 [No Abstract] [Full Text] [Related]
3. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations. Cavusoglu C; Karaca-Derici Y; Bilgic A Clin Microbiol Infect; 2004 Jul; 10(7):662-5. PubMed ID: 15214882 [TBL] [Abstract][Full Text] [Related]
4. Cross-resistance between rifampicin and KRM-1648 is associated with specific rpoB alleles in Mycobacterium tuberculosis. Park YK; Kim BJ; Ryu S; Kook YH; Choe YK; Bai GH; Kim SJ Int J Tuberc Lung Dis; 2002 Feb; 6(2):166-70. PubMed ID: 11931418 [TBL] [Abstract][Full Text] [Related]
5. Use of a high-density DNA probe array for detecting mutations involved in rifampicin resistance in Mycobacterium tuberculosis. Sougakoff W; Rodrigue M; Truffot-Pernot C; Renard M; Durin N; Szpytma M; Vachon R; Troesch A; Jarlier V Clin Microbiol Infect; 2004 Apr; 10(4):289-94. PubMed ID: 15059116 [TBL] [Abstract][Full Text] [Related]
6. Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates. Soudani A; Hadjfredj S; Zribi M; Masmoudi A; Messaoud T; Tiouri H; Fendri C J Clin Microbiol; 2007 Sep; 45(9):3095-7. PubMed ID: 17652484 [TBL] [Abstract][Full Text] [Related]
7. Multiplex detection of mutations in clinical isolates of rifampin-resistant Mycobacterium tuberculosis by short oligonucleotide ligation assay on DNA chips. Deng JY; Zhang XE; Lu HB; Liu Q; Zhang ZP; Zhou YF; Xie WH; Fu ZJ J Clin Microbiol; 2004 Oct; 42(10):4850-2. PubMed ID: 15472360 [TBL] [Abstract][Full Text] [Related]
8. [Detecting rpoB gene mutation in rifampin-resistant Mycobacterium tuberculosis by using the reverse dot-blot hybridization method]. Wang W; Pan W; Jin W; Weng X; Yan R; Su B; Chen S; Zhang W; Lu H; Qi Z Zhonghua Jie He He Hu Xi Za Zhi; 2002 Oct; 25(10):591-4. PubMed ID: 12490124 [TBL] [Abstract][Full Text] [Related]
9. [Bacteriostatic effect of rifampicin (Rifampin) on Mycobacterium tuberculosis in vitro]. Woźniak S; Tomaszkiewicz L; Zierski M Gruzlica; 1969 Nov; 37(11):983-9. PubMed ID: 4983868 [No Abstract] [Full Text] [Related]
10. [A new method of determining the rifampicin resistance of Mycobacterium tuberculosis]. Reutgen H Acta Biol Med Ger; 1972; 28(3):395-409. PubMed ID: 4626094 [No Abstract] [Full Text] [Related]
11. [In-vitro action of rifampicin on strains of tuberculous and atypical mycobacteria]. Denis-Bottin C Acta Tuberc Pneumol Belg; 1972; 63(1):127-39. PubMed ID: 4631815 [No Abstract] [Full Text] [Related]
12. Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis. Kurabachew M; Lu SH; Krastel P; Schmitt EK; Suresh BL; Goh A; Knox JE; Ma NL; Jiricek J; Beer D; Cynamon M; Petersen F; Dartois V; Keller T; Dick T; Sambandamurthy VK J Antimicrob Chemother; 2008 Oct; 62(4):713-9. PubMed ID: 18587134 [TBL] [Abstract][Full Text] [Related]
13. [Rifampicin sensitivity of mycobacteria]. Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P Ann Ist Carlo Forlanini; 1969; 29(1):17-28. PubMed ID: 4996680 [No Abstract] [Full Text] [Related]
14. "In vitro" action of rifampicin on typical and atypical mycobacteria. Tanzil HO; Chatim A; Rachim A; Judanarso D Acta Tuberc Pneumol Belg; 1972; 63(1):140-7. PubMed ID: 4631816 [No Abstract] [Full Text] [Related]
16. [Comparative bactericidal action of rifampicin alone on M. tuberculosis and M. leprae]. Guelpa-Lauras CC; Grosset J; Truffot-Pernot C; Giroir AM Acta Leprol; 1982; (86-87):69-75. PubMed ID: 6815999 [No Abstract] [Full Text] [Related]
17. [The sensitivity of Mycobacterium tuberculosis to rifampicin and its clinical effectiveness (author's transl)]. Chen HL Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Feb; 3(2):104-5. PubMed ID: 6774865 [No Abstract] [Full Text] [Related]
18. Rifampicin-susceptibility and rifampicin-resistance in mycobacteria. Manten A; van Wijngaarden LJ; van Klingeren B Acta Tuberc Pneumol Belg; 1969; 60(3):329-34. PubMed ID: 4984415 [No Abstract] [Full Text] [Related]
19. [Resistance to rifampin of mycobacterium tuberculosis and rpoB gene]. Huang H; Ma Y Zhonghua Jie He He Hu Xi Za Zhi; 2000 Nov; 23(11):692-4. PubMed ID: 11225038 [No Abstract] [Full Text] [Related]
20. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs. Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]